Company News

October 13, 2020

UBS Now Covering the Mattress Sector

Purple Innovation the top pick at UBS in sweeping coverage of mattress sector

Oct. 13, 2020 7:46 AM ET|About: Purple Innovation, Inc. (PRPL)|By: Clark Schultz, SA News Editor

UBS takes up coverage on the U.S. mattress industry with four new ratings as it looks at housing as a near-term tailwind.

Analyst Atul Maheswari: “We believe the mattress sector should see strong trends over the next few quarters on the back of wallet share gains and continued strength in housing. Some of the long-term unknowns like the shift online & intense competition will likely take a backseat to unit gains over the next couple of quarters. Our top down industry model forecasts the $21 bn mattress industry growing 5.4% in 2020 followed by 4.1% in FY’21. Our 2020 estimate bakes in a -LSD decline for the ~$16.5 bn traditional channel and 35% growth for the ~$4bn DTC channel.”

Purple Innovation (NASDAQ:PRPL) is the top pick in the group from UBS. “PRPL is a profitable DTC player with several unique drivers to sustain 20-25% revenue growth and 25%+ EBITDA growth over an extended period of time. Still, it’s trading at just 13x FY’22E EBITDA and ~2x EV/Sales, which is below its consumer/retail high growth peers (FIVE/FND),” previews the firm. Coverage is launched by UBS with a Buy rating.

Tempur-Sealy International (NYSE:TPX) and Casper (NYSE:CSPR) are started off at Neutral. “We believe TPX will capitalize on industry tailwinds & should report strong trends in the near term. However, there are concerns on how it will lap these gains in 2H’21. This will likely act as an overhang on the stock. Finally, we believe CSPR needs to show better balance between sales growth & profitability for its shares to attract a higher valuation,” updates UBS.

Sleep Number (NASDAQ:SNBR) is seen as the laggard and initiated with a Sell rating. “SNBR’s lofty valuations (22x NTM P/E) coupled with mall exposure and low online penetration keeps us cautious on the name,” warns UBS.

https://seekingalpha.com/news/3621624-purple-innovation-top-pick-ubs-in-sweeping-coverage-of-mattress-sector?utm_medium=email&utm_source=seeking_alpha&mail_subject=tpx-cspr-purple-innovation-the-top-pick-at-ubs-in-sweeping-coverage-of-mattress-sector&utm_campaign=rta-stock-news&utm_content=link-3

October 13, 2020

UBS Now Covering the Mattress Sector

Purple Innovation the top pick at UBS in sweeping coverage of mattress sector

Oct. 13, 2020 7:46 AM ET|About: Purple Innovation, Inc. (PRPL)|By: Clark Schultz, SA News Editor

UBS takes up coverage on the U.S. mattress industry with four new ratings as it looks at housing as a near-term tailwind.

Analyst Atul Maheswari: “We believe the mattress sector should see strong trends over the next few quarters on the back of wallet share gains and continued strength in housing. Some of the long-term unknowns like the shift online & intense competition will likely take a backseat to unit gains over the next couple of quarters. Our top down industry model forecasts the $21 bn mattress industry growing 5.4% in 2020 followed by 4.1% in FY’21. Our 2020 estimate bakes in a -LSD decline for the ~$16.5 bn traditional channel and 35% growth for the ~$4bn DTC channel.”

Purple Innovation (NASDAQ:PRPL) is the top pick in the group from UBS. “PRPL is a profitable DTC player with several unique drivers to sustain 20-25% revenue growth and 25%+ EBITDA growth over an extended period of time. Still, it’s trading at just 13x FY’22E EBITDA and ~2x EV/Sales, which is below its consumer/retail high growth peers (FIVE/FND),” previews the firm. Coverage is launched by UBS with a Buy rating.

Tempur-Sealy International (NYSE:TPX) and Casper (NYSE:CSPR) are started off at Neutral. “We believe TPX will capitalize on industry tailwinds & should report strong trends in the near term. However, there are concerns on how it will lap these gains in 2H’21. This will likely act as an overhang on the stock. Finally, we believe CSPR needs to show better balance between sales growth & profitability for its shares to attract a higher valuation,” updates UBS.

Sleep Number (NASDAQ:SNBR) is seen as the laggard and initiated with a Sell rating. “SNBR’s lofty valuations (22x NTM P/E) coupled with mall exposure and low online penetration keeps us cautious on the name,” warns UBS.

https://seekingalpha.com/news/3621624-purple-innovation-top-pick-ubs-in-sweeping-coverage-of-mattress-sector?utm_medium=email&utm_source=seeking_alpha&mail_subject=tpx-cspr-purple-innovation-the-top-pick-at-ubs-in-sweeping-coverage-of-mattress-sector&utm_campaign=rta-stock-news&utm_content=link-3

October 12, 2020

BASF Announces Polyol Hike for Thursday

October 12, 2020

Dear Valued Customer,


Effective October 15, 2020 or as contracts allow, BASF Corporation is raising the price for all Pluracol® polyol products by $0.12 per pound.


Your BASF Account Manager will provide further details of this announced increase and is available to answer any questions you may have. We appreciate your continued support for BASF Urethane Chemicals.

October 12, 2020

BASF Announces Polyol Hike for Thursday

October 12, 2020

Dear Valued Customer,


Effective October 15, 2020 or as contracts allow, BASF Corporation is raising the price for all Pluracol® polyol products by $0.12 per pound.


Your BASF Account Manager will provide further details of this announced increase and is available to answer any questions you may have. We appreciate your continued support for BASF Urethane Chemicals.

October 9, 2020

BASF Q3 Forecast

BASF Expects Swing to 3Q Net Loss; Issues 2020 Forecast

Provided by Dow Jones Oct 9, 2020 9:04 AM EDT

   By Joshua Kirby 
 

BASF SE said Friday that it expects to swing to a net loss for the third quarter due to impairments and restructuring, and it issued guidance for the full year.

The German chemical company reported a preliminary net loss of 2.12 billion euros ($2.49 billion) for the quarter, down from a net profit of EUR911 million a year earlier and below consensus estimates.

BASF expects a third-quarter loss before interest and taxes of EUR2.64 billion, compared with EBIT of EUR1.34 billion a year prior.

Earnings were hit by coronavirus-related impairments relating to weaker demand in the automotive and aviation industries that amounted to EUR2.8 billion, BASF said, as well as provisions for restructuring.

Quarterly sales are expected to decline 5% on year to EUR13.81 billion from EUR14.56 billion.

For the full year, BASF expects EBIT before special items of between EUR3.0 billion and EUR3.3 billion–down from EUR4.64 billion in 2019–and sales of between EUR57 billion and EUR58 billion, compared with EUR59.32 billion a year earlier.

“As well as weaker demand, the company expects pressure on margins to continue, especially for basic chemicals, which will be partially offset by fixed cost savings,” the company said.

BASF will report final third-quarter results on Oct. 28.

https://www.morningstar.com/news/dow-jones/202010094546/basf-expects-swing-to-3q-net-loss-issues-2020-forecast